HomeCompareFMPOX vs MRK

FMPOX vs MRK: Dividend Comparison 2026

FMPOX yields 7.58% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FMPOX wins by $2.3K in total portfolio value
10 years
FMPOX
FMPOX
● Live price
7.58%
Share price
$31.10
Annual div
$2.36
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.0K
Annual income
$1,225.20
Full FMPOX calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — FMPOX vs MRK

📍 FMPOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFMPOXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FMPOX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FMPOX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FMPOX
Annual income on $10K today (after 15% tax)
$644.20/yr
After 10yr DRIP, annual income (after tax)
$1,041.42/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, FMPOX beats the other by $233.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FMPOX + MRK for your $10,000?

FMPOX: 50%MRK: 50%
100% MRK50/50100% FMPOX
Portfolio after 10yr
$31.9K
Annual income
$1,087.75/yr
Blended yield
3.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FMPOX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FMPOX buys
0
MRK buys
0
No recent congressional trades found for FMPOX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFMPOXMRK
Forward yield7.58%3.25%
Annual dividend / share$2.36$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$33.0K$30.7K
Annual income after 10y$1,225.20$950.29
Total dividends collected$10.0K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FMPOX vs MRK ($10,000, DRIP)

YearFMPOX PortfolioFMPOX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,458$757.88$11,192$351.54+$266.00FMPOX
2$13,071$811.56$12,524$392.70+$547.00FMPOX
3$14,852$865.28$14,015$438.65+$837.00FMPOX
4$16,810$918.81$15,682$489.96+$1.1KFMPOX
5$18,959$971.93$17,547$547.23+$1.4KFMPOX
6$21,310$1,024.45$19,632$611.16+$1.7KFMPOX
7$23,878$1,076.19$21,963$682.53+$1.9KFMPOX
8$26,677$1,126.98$24,571$762.18+$2.1KFMPOX
9$29,721$1,176.69$27,486$851.08+$2.2KFMPOX
10$33,027$1,225.20$30,745$950.29+$2.3KFMPOX

FMPOX vs MRK: Complete Analysis 2026

FMPOXStock

The fund normally invests at least 80% of its assets in securities of companies with medium market capitalizations (which, for purposes of this fund, are those companies with market capitalizations similar to companies in the Russell Midcap® Index or the S&P MidCap 400® Index). It invests in companies with smaller or larger market capitalizations. The fund invests in domestic and foreign issuers.

Full FMPOX Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this FMPOX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FMPOX vs SCHDFMPOX vs JEPIFMPOX vs OFMPOX vs KOFMPOX vs MAINFMPOX vs JNJFMPOX vs ABBVFMPOX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.